Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-17

Clinical Trial Update: Safety and Efficacy Study of TNX-201 Capsules for Treatment of Single Tension-Type Headache [Phase 2]

View source ↗

Summary

Phase 2 study of TNX-201 capsules for tension-type headache has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TNX-201 capsules (TNX-201)

Snippet

Sponsor: Tonix Pharmaceuticals, Inc. | Conditions: Tension-Type Headache | Phase 2 | Status: COMPLETED | Results posted: 2017-02-17